mRNA Archives -

Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of

mRNA can deliver universal flu vaccine, say US researchers

https://pharmaphorum.com/news/mrna-can-deliver-universal-flu-vaccine-say-us-researchers/

Preparing for an influx of cell and gene therapy approvals

CapstanTx secures $165 million to deliver precise in vivo cell engineering

Nicole Raleigh Capstan Therapeutics, CAR-T therapy, cell therapy, in vivo, investment, Lipid Nanoparticles, mRNA, pharma, tLNP 0 Comment

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it

CapstanTx secures $165 million to deliver precise in vivo cell engineering

https://pharmaphorum.com/news/capstantx-secures-165-million-to-deliver-precise-in-vivo-cell-engineering/

News/ News/ R&D

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

Phil Taylor BioNTech, CureVac, GlaxoSmithKline, influenza, Moderna, mRNA, Pfizer, Sanofi, Translate Bio, vaccines 0 Comment

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza vaccine developed

Pfizer, BioNTech’s mRNA flu vaccine starts phase 3 testing

https://pharmaphorum.com/news/pfizer-biontechs-mrna-flu-vaccine-starts-phase-3-testing/

News/ News/ Oncology

ESMO: Evidence builds for BioNTech’s amplified CAR-T therapy

Phil Taylor BioNTech, CAR-T therapies, ESMO 2022, immuno-oncology, mRNA, Oncology, vaccine 0 Comment

BioNTech has been thrust into the limelight with its mRNA-based vaccines and therapeutics – most notably its Pfizer-partnered

ESMO: Evidence builds for BioNTech’s amplified CAR-T therapy

https://pharmaphorum.com/news/esmo-evidence-builds-for-biontechs-amplified-car-t-therapy/

R&D/ Views & Analysis/ Views and analysis

Now is the time for pharma to help solve bias in clinical trials

mike.hammerton@pharmaphorum.com Accenture, bias, clinical trials, diversity, Health data, mRNA, pharma, public health, regulatory bodies 0 Comment

Pharma has a great opportunity ahead of it when it comes to conducting representative clinical trials. The industry’s

Now is the time for pharma to help solve bias in clinical trials

https://pharmaphorum.com/r-d/now-is-the-time-for-pharma-to-help-solve-bias-in-clinical-trials/

Health Innovation Fund, Moderna’s largest shareholder, shares investment strategies

Digital/ Views & Analysis/ Views and analysis

Baillie Gifford, Moderna’s largest shareholder, shares investment strategies

Jessica Hagen Broad Institue, Health Innovation Fund, Moderna, mRNA 0 Comment

Jack Torrance, investment specialist for Baillie Gifford’s Health Innovation Fund, tells us how the organisation ensures its investments

Baillie Gifford, Moderna’s largest shareholder, shares investment strategies

https://pharmaphorum.com/digital/health-innovation-fund-modernas-largest-shareholder-shares-investment-strategies/

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

Podcast

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

Jonah Comstock COVID-19, gene silencing, gene therapy, mRNA, Silence Therapeutics 0 Comment

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

https://pharmaphorum.com/podcast/gene-silencing-mrna-breakthroughs-and-barriers/

Podcast/ R&D/ Slider in video/ Video/ Views & Analysis/ Views and analysis

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

Jonah Comstock COVID-19, gene silencing, gene therapy, mRNA, Silence Therapeutics 0 Comment

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular

Gene silencing and mRNA: breakthroughs and barriers – the pharmaphorum podcast

https://pharmaphorum.com/r-d/gene-silencing-and-mrna-breakthroughs-and-barriers/

News/ News/ R&D

NIH starts trial of Moderna’s mRNA Nipah virus vaccine

Phil Taylor Moderna, mRNA, NIAID, NIH, Nipah virus, vaccine 0 Comment

Researchers in the US have started a clinical trial of a vaccine against Nipah virus, a serious infection

NIH starts trial of Moderna’s mRNA Nipah virus vaccine

https://pharmaphorum.com/news/nih-starts-trial-of-modernas-mrna-nipah-virus-vaccine/

Trending

mRNA

Login